SEC
SlamSEC
SearchBrowseEarnings

Silo Pharma, Inc.

Nasdaq:SILO
Pharmaceutical Preparations·SARASOTA, FL
OverviewAll FilingsSum FinCreditInsidersGovernance
OverviewAll FilingsSum FinCreditInsidersGovernance

All Filings(348 total)

TypeDateAccessionPeriodSize
8-K
Feb 23, 2026
0001213900-26-019384CURRENT REPORT
Feb 20, 2026
195.7 KB
SCHEDULE 13G/A
Feb 17, 2026
0001193125-26-053479
—
33.0 KB
SCHEDULE 13G/A
Feb 13, 2026
0001213900-26-016528
—
12.7 KB
SCHEDULE 13G/A
Feb 13, 2026
0001213900-26-016071
—
6.9 KB
8-K
Dec 29, 2025
0001213900-25-125838CURRENT REPORT
Dec 24, 2025
186.8 KB
4
Dec 16, 2025
0001213900-25-122429
Dec 15, 2025
6.1 KB
EFFECT
Nov 26, 2025
9999999995-25-003402
—
1.9 KB
424B3
Nov 26, 2025
0001213900-25-115503PROSPECTUS
—
407.2 KB
4
Nov 21, 2025
0001213900-25-113743
Nov 20, 2025
6.1 KB
4
Nov 20, 2025
0001213900-25-113104
Nov 18, 2025
7.2 KB
SCHEDULE 13G
Nov 14, 2025
0001193125-25-282676
—
32.4 KB
10-Q
Nov 13, 2025
0001213900-25-110006QUARTERLY REPORT
Sep 30, 2025
5.9 MB
SCHEDULE 13G/A
Nov 7, 2025
0001213900-25-107728
—
13.2 KB
S-1
Oct 29, 2025
0001213900-25-103188REGISTRATION STATEMENT
—
487.8 KB
8-K
Oct 24, 2025
0001213900-25-102222CURRENT REPORT
Oct 24, 2025
215.8 KB
SCHEDULE 13G
Oct 3, 2025
0001213900-25-096008
—
7.0 KB
8-K
Oct 1, 2025
0001213900-25-094711CURRENT REPORT
Sep 29, 2025
793.0 KB
424B5
Oct 1, 2025
0001213900-25-094384PROSPECTUS SUPPLEMENT
—
486.0 KB
DEFA14A
Sep 5, 2025
0001213900-25-085128DEFINITIVE ADDITIONAL MATERIALS
—
3.1 MB
ARS
Sep 5, 2025
0001213900-25-085125ARS
Dec 31, 2024
777.4 KB
DEF 14A
Sep 5, 2025
0001213900-25-085119DEFINITIVE PROXY STATEMENT
Oct 24, 2025
4.2 MB
PRE 14A
Aug 25, 2025
0002077096-25-000053PRELIMINARY PROXY STATEMENT
Aug 25, 2025
3.8 MB
424B5
Aug 18, 2025
0001213900-25-077936PROSPECTUS SUPPLEMENT
—
956.5 KB
10-Q
Aug 13, 2025
0001213900-25-075693QUARTERLY REPORT
Jun 30, 2025
5.2 MB
SCHEDULE 13G/A
Aug 12, 2025
0001213900-25-075089
—
12.3 KB
25 filings shown

A silo is a structure for storing bulk materials.

CEO
Weisblum Eric
CFO
Ryweck Daniel E.